000 01807 a2200541 4500
005 20250515034527.0
264 0 _c20070423
008 200704s 0 0 eng d
022 _a0954-6111
024 7 _a10.1016/j.rmed.2006.06.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKarpel, Jill P
245 0 0 _aInhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
_h[electronic resource]
260 _bRespiratory medicine
_cMar 2007
300 _a628-37 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial
650 0 4 _aAdministration, Inhalation
650 0 4 _aAdministration, Oral
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnti-Inflammatory Agents
_xadministration & dosage
650 0 4 _aAsthma
_xdrug therapy
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aGlucocorticoids
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aLung
_xdrug effects
650 0 4 _aMale
650 0 4 _aMetered Dose Inhalers
650 0 4 _aMiddle Aged
650 0 4 _aMometasone Furoate
650 0 4 _aPrednisone
_xadministration & dosage
650 0 4 _aPregnadienediols
_xadministration & dosage
650 0 4 _aQuality of Life
650 0 4 _aTreatment Outcome
700 1 _aNayak, Anjuli
700 1 _aLumry, William
700 1 _aCraig, Timothy J
700 1 _aKerwin, Edward
700 1 _aFish, James E
700 1 _aLutsky, Barry
773 0 _tRespiratory medicine
_gvol. 101
_gno. 3
_gp. 628-37
856 4 0 _uhttps://doi.org/10.1016/j.rmed.2006.06.005
_zAvailable from publisher's website
999 _c16464777
_d16464777